CBIC CIC - CBIC Certified Infection Control Exam

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies silver as an anti-infective material commonly incorporated into medical devices such as endotracheal tubes, urinary catheters, and intravascular catheters. Silver has broad-spectrum antimicrobial properties against bacteria, fungi, and some viruses. When used as a coating or impregnated material, silver ions disrupt microbial cell membranes, interfere with enzyme systems, and inhibit replication—thereby reducing microbial colonization and biofilm formation on device surfaces.

Device-associated infections often originate from colonization of indwelling devices. Silver-coated or silver-impregnated devices are intended to reduce the risk of healthcare-associated infections by limiting early microbial adherence and growth, particularly during the highest-risk period shortly after device insertion. Examples include silver alloy urinary catheters for CAUTI prevention and silver-coated endotracheal tubes designed to reduce ventilator-associated events.

The other options listed are not used in this context. Copper has antimicrobial properties but is not commonly used in indwelling medical devices. Chromium is used for corrosion resistance in alloys, not for infection prevention. Zinc plays roles in wound care and topical formulations but is not standard for catheter or tube coatings.

For CIC® exam preparation, recognizing silver as the anti-infective material used in multiple indwelling devices is important, as it reflects evidence-based strategies aimed at reducing device-associated infection risk.

==========

The correct answer is A, "Pregnant persons," as they should be excluded from receiving the live attenuated influenza virus (LAIV) vaccine. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), the LAIV, commonly known as the nasal spray flu vaccine, contains a live attenuated form of the influenza virus. This vaccine is contraindicated in pregnant individuals due to the theoretical risk of the attenuated virus replicating and potentially harming the fetus, despite limited evidence of adverse outcomes (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). Pregnant persons are instead recommended to receive the inactivated influenza vaccine (IIV), which is considered safe during pregnancy.

Option B (healthy persons aged 2 to 49) is incorrect because this group is generally eligible to receive LAIV, provided they have no other contraindications, as the vaccine is approved for healthy, non-pregnant individuals in this age range (CDC Immunization Schedules, 2024). Option C (persons with allergies to chicken feathers) is not a contraindication for LAIV; the vaccine is produced in eggs, and while egg allergy was historically a concern, current guidelines indicate that LAIV can be administered to persons with egg allergies if they can tolerate egg in their diet, with precautions managed by healthcare providers. Option D (persons simultaneously receiving an inactivated vaccine) is also incorrect, as LAIV can be co-administered with inactivated vaccines without issue, according to ACIP recommendations, as there is no significant interference between the two vaccine types.

The exclusion of pregnant persons reflects CBIC’s emphasis on tailoring infection prevention strategies, including vaccination programs, to protect vulnerable populations while minimizing risks (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This decision is based on precautionary principles outlined in CDC and ACIP guidelines to ensure maternal and fetal safety (CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023).

The correct answer is C, "results of biologic indicators are unavailable prior to use of the item," as this is the primary reason immediate use steam sterilization (IUSS) is not recommended for implantable items requiring immediate use. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, IUSS is a process used for sterilizing items needed urgently when no other sterile options are available, typically involving a shortened cycle (e.g., flash sterilization). However, for implantable items—such as orthopedic hardware or prosthetic devices—ensuring absolute sterility is critical due to the risk of deep infection. Biologic indicators (BIs), which contain highly resistant spores to verify sterilization efficacy, require incubation (typically 24-48 hours) to confirm the kill, but IUSS does not allow time for BI results to be available before the item is used (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This lack of immediate verification poses a significant infection risk, making IUSS inappropriate for implants, as per AAMI ST79 standards.

Option A (the high temperature may damage the items) is a consideration for some heat-sensitive materials, but modern IUSS cycles are designed to minimize damage, and this is not the primary reason for the restriction on implants. Option B (chemical indicators may not be accurate at high temperatures) is incorrect, as chemical indicators (e.g., color-changing strips) are reliable at high temperatures and serve as an immediate check, though they are not a substitute for BIs. Option D (the length of time is inadequate for the steam to penetrate the pack) is not the main issue, as IUSS cycles are optimized for penetration, though the shortened time may be a secondary concern; the unavailability of BI results remains the decisive factor.

The focus on biologic indicator results aligns with CBIC’s emphasis on ensuring the safety and sterility of reprocessed medical devices, particularly for high-risk implantable items (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This recommendation is supported by AAMI and CDC guidelines, which prioritize BI confirmation for implants to prevent healthcare-associated infections (AAMI ST79:2017, CDC Sterilization Guidelines, 2019).

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies nontuberculous mycobacteria (NTM) as organisms commonly associated with waterborne exposure. NTM are environmental mycobacteria widely found in natural and treated water sources, including potable water systems, ice machines, showerheads, faucets, and medical equipment rinsed with tap water. Because these organisms are resistant to standard water disinfection methods and can form biofilms, they are particularly well adapted to survive in plumbing systems.

NTM have been implicated in healthcare-associated infections, especially among immunocompromised patients, and may cause pulmonary disease, skin and soft tissue infections, and invasive disease following exposure to contaminated water or medical devices. The Study Guide emphasizes the importance of water management programs and routine surveillance to prevent waterborne transmission of opportunistic pathogens such as NTM and Legionella.

The other answer options are incorrect. Bacillus anthracis is primarily associated with zoonotic and bioterrorism-related exposure, not waterborne transmission. Cytomegalovirus is transmitted through direct contact with bodily fluids rather than water. Stachybotrys is a mold associated with damp indoor environments but is not considered a waterborne pathogen in the context of infection transmission.

Understanding organisms linked to water systems is critical for infection preventionists, as waterborne pathogens present ongoing risks in healthcare facilities and are a key topic on the CIC® exam.

==========

Group B Streptococcus (Streptococcus agalactiae) is the most common cause of neonatal bacterial meningitis beyond one week of age.

Step-by-Step Justification:

Group B Streptococcus (GBS) and Neonatal Infections:

GBS is a leading cause of late-onset neonatal meningitis (occurring after 7 days of age)​.

Infection typically occurs through vertical transmission from the mother or postnatal exposure.

Neonatal Risk Factors:

Premature birth, prolonged rupture of membranes, and maternal GBS colonization increase risk​.

Why Other Options Are Incorrect:

A. Group A: Rare in neonates and more commonly associated with pharyngitis and skin infections.

C. Group C: Typically associated with animal infections and rarely affects humans.

D. Group D: Includes Enterococcus, which can cause neonatal infections but is not the most common cause of meningitis.

CBIC Infection Control References:

APIC Text, "Group B Streptococcus and Neonatal Meningitis"​.

The CBIC Certified Infection Control Exam Study Guide (6th edition) describes prospective surveillance as an active, real-time approach to infection surveillance in which patients are monitored as care is being delivered. The primary advantage of this method is its ability to identify infections, trends, and clusters promptly, allowing for early intervention and rapid implementation of control measures.

Because prospective surveillance occurs concurrently with patient care, infection preventionists can detect emerging patterns—such as an increase in device-associated infections or unusual organisms—before they become widespread outbreaks. This timely recognition supports immediate corrective actions, such as reinforcing isolation precautions, modifying clinical practices, or initiating focused investigations, thereby reducing transmission and patient harm.

The other options describe characteristics that are more consistent with retrospective surveillance. Option A and C are incorrect because prospective surveillance is typically more resource- and labor-intensive, not necessarily efficient or cost-effective. Option B is also incorrect because complete laboratory data may not yet be available in real time, whereas retrospective surveillance benefits from finalized records.

For the CIC® exam, it is important to understand that although prospective surveillance requires more resources, its key strength lies in early detection and timely response. The ability to quickly identify clusters of infection and intervene promptly is the defining advantage of prospective surveillance and the reason it is preferred for high-risk settings and priority infections.

Immediate feedback is a best practice in behavior correction and performance improvement. In hand hygiene non-compliance, real-time intervention allows for immediate correction, education, and reinforcement of infection prevention policies.

The APIC/JCR Workbook recommends:

“Provide simulation training… that provides immediate feedback—for example, how to properly insert a urinary catheter or perform hand hygiene.” This supports behavior change and staff learning.

The APIC Text emphasizes that real-time, direct feedback is more effective than passive measures like signage or delayed education campaigns.

Early detection of emerging public health threats depends on receiving timely, actionable information that can trigger rapid assessment and response within the facility. The Certification Study Guide emphasizes preparedness for biologic threats and emerging infectious diseases as part of core infection prevention practice (e.g., planning for an influx of patients with communicable diseases and responding to emerging infections). Subscribing to public health alerts is the most effective option because alerts are designed to push critical updates (case definitions, exposure risks, recommended control measures, and reporting expectations) as soon as they are identified by public health authorities—minimizing delay compared with periodically checking websites.

Why the other options are incorrect:

A is reactive and can miss urgent updates between scheduled checks.

C supports ongoing education but is not a real-time early warning system.

D is important for facility-level detection, but emerging threats are often identified first through public health surveillance and communications beyond a single facility’s lab.

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies inadequate hand hygiene as the most common and significant factor associated with healthcare-associated transmission of methicillin-resistant Staphylococcus aureus (MRSA). MRSA is primarily transmitted via direct contact, most often through the hands of healthcare personnel after contact with colonized or infected patients or contaminated environmental surfaces.

While MRSA-infected or colonized patients serve as reservoirs for the organism, transmission does not occur unless there is a breakdown in infection prevention practices, particularly hand hygiene. Numerous studies and surveillance findings cited in the Study Guide demonstrate that adherence to hand hygiene protocols—before and after patient contact, after contact with bodily fluids, and after contact with the patient environment—is the single most effective measure to reduce MRSA spread within healthcare facilities.

Improper ventilation (Option A) is associated with airborne pathogens, not MRSA, which is not transmitted via the airborne route. MRSA-colonized healthcare workers (Option D) are far less commonly implicated in transmission than transient hand contamination, and routine screening of staff is not recommended except during specific outbreak investigations. Option B describes a reservoir, not the primary mechanism of transmission.

For CIC® exam purposes, this question reinforces a foundational principle of infection prevention: failure to perform appropriate hand hygiene is the leading cause of healthcare-associated MRSA transmission, making it the correct and best answer.

The incidence rate measures new cases of infection in a population over a defined time period using the formula:

Why the Other Options Are Incorrect?

B. Disease specific – Refers to infections caused by a particular pathogen, not the general rate of new infections.

C. Point prevalence – Measures existing cases at a specific point in time, not new cases.

D. Period prevalence – Includes both old and new cases over a set period, unlike incidence, which only considers new cases.

CBIC Infection Control Reference

APIC defines incidence rate as the number of new infections in a population over a given period​.